B

Beijing Airdoc Technology Co Ltd
HKEX:2251

Watchlist Manager
Beijing Airdoc Technology Co Ltd
HKEX:2251
Watchlist
Price: 12.1 HKD 1.17% Market Closed
Market Cap: 1.3B HKD
Have any thoughts about
Beijing Airdoc Technology Co Ltd?
Write Note

Beijing Airdoc Technology Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Airdoc Technology Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Airdoc Technology Co Ltd
HKEX:2251
Cash from Investing Activities
-ÂĄ385.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Cash from Investing Activities
ÂĄ466.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medlive Technology Co Ltd
HKEX:2192
Cash from Investing Activities
-ÂĄ634.9m
CAGR 3-Years
N/A
CAGR 5-Years
-190%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Cash from Investing Activities
-ÂĄ104.7m
CAGR 3-Years
-89%
CAGR 5-Years
2%
CAGR 10-Years
-6%
B-SOFT Co Ltd
SZSE:300451
Cash from Investing Activities
-ÂĄ318.5m
CAGR 3-Years
-31%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Cash from Investing Activities
-ÂĄ334.8m
CAGR 3-Years
-17%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
No Stocks Found

Beijing Airdoc Technology Co Ltd
Glance View

Market Cap
1.3B HKD
Industry
Health Care

Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. The company is headquartered in Beijing, Beijing and currently employs 369 full-time employees. The company went IPO on 2021-11-05. The firm's main product is Airdoc-AIFUNDUS 1.0. The firm's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.

Intrinsic Value
19.61 HKD
Undervaluation 38%
Intrinsic Value
Price
B

See Also

What is Beijing Airdoc Technology Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-385.1m CNY

Based on the financial report for Dec 31, 2023, Beijing Airdoc Technology Co Ltd's Cash from Investing Activities amounts to -385.1m CNY.

What is Beijing Airdoc Technology Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
-149%

Over the last year, the Cash from Investing Activities growth was -149%.

Back to Top